The Fed’s regulatory chief recently weighed in on a path to improvement following a string of midsize bank failures. Eli Lilly’s Retatrutide medication was recently under the WSJ spotlight for its surprising results. Rite Aid’s stock just hit a record low. We’re discussing these topics and more in Episode 11.------

11 - Inflation | Jobs & the Fed | Top-heavy Nasdaq & S&P500 | Pharma solution for many chronic diseases | Rite-Aid debt concerns

Every week, healthcare VCs and Jumpstart Health Investors co-founders Vic Gatto and Marcus Whitney review and unpack the happenings in US Healthcare, finance, technology and policy. With a firm belief that our healthcare system is doomed without entrepreneurship, they work through the mud to find the jewels, highlight headwinds and tailwinds, and bring on the smartest guests to fill in the gaps.

Business

Investing

Careers

Management & Marketing

Business News

Shopping

Medicine

Science & Medicine

Health & Fitness

In this episode, Vic and Marcus dive deep into the intersection of tech, healthcare, and AI advancements, shedding light on how these developments are reshaping the way we approach health, coding, and our daily lives. From exploring the latest in AI coding tools like GitHub Copilot Workspace to discussing the ethical and practical implications of AI in medicine, this episode offers a comprehensive overview of the cutting-edge technologies at the forefront of innovation. They also tackle the complex world of healthcare policy changes, the relentless pursuit of longevity, and the evolving landscape of pharmacy services, providing our listeners with a panoramic view of the challenges and opportunities that lie ahead.Please check out our Episode Resources below:------

Ep 58 - Walmart Health Centers Closed, Marijuana Reclassified, South Bans Abortion, Kaiser's AI

In this insightful episode, join us as we delve into the complexities of heart disease with Dr. Reddy, a cardiac surgeon with over two decades of experience. From understanding the early onset of heart disease to discussing its treatment options, including the revolutionary TAVR procedure and the promising future of cardiac care, this episode is packed with invaluable knowledge. Whether you're curious about how heart disease affects the body or interested in the latest surgical advancements, this conversation sheds light on the myriad aspects of cardiac health.Please check out our Episode Resources below:------

57 - Understanding Heart Disease w/ Cardiac Surgery Dr. Seenu Reddy

In this solo episode, we dive into the latest economic indicators revealing disappointing U.S. GDP growth and what it means for the Fed, the Biden administration, and the healthcare industry amidst an election year. We explore significant healthcare deals, including telehealth advancements and AI contributions to medical billing, alongside payer news highlighting earnings and Medicaid updates. The episode also touches on regulatory shifts affecting labor and non-compete agreements and concludes with intriguing AI developments in healthcare. Join us for an insightful discussion on how these elements intertwine to shape our economic and healthcare landscapes.Please check out our Episode Resources below:------

56 - Humana $741m, Optum Layoffs, FTC Bans Noncompete, Hip Fracture Survival Lower Than Cancer

In this episode, Marcus and Vic dive into the heart of healthcare innovation, economic dynamics, and the growing intersection of artificial intelligence in medicine. The conversation spans the gamut from heart care advancements that personalize and improve patient outcomes to the broader implications of economic policies on healthcare accessibility and affordability. Our exploration doesn't stop there; we also uncover the challenges and opportunities presented by AI in revolutionizing drug discovery and patient care protocols while also taking a critical look at the cybersecurity measures essential in safeguarding our healthcare data. This episode provides an overview of the current landscape and future directions of healthcare, emphasizing the role of technology in shaping a healthier, more informed society.Please check out our Episode Resources below:------

55 - United and Elevance Earnings, PE Risk Index, Healthcare LLM Rankings, Atlas Robot

In this episode, Vic, Marcus, and Emily Evans (Managing Director at Hedgeye Risk Management, LLC) dive deep into healthcare policy, focusing on the seismic shifts within the Medicare Advantage landscape. They unravel the complexities surrounding UnitedHealth Group’s latest financials, dissecting the impacts of demographic shifts, policy changes, and earnings reports on the Medicare Advantage program. The trio also scrutinizes the evolving dynamics of healthcare spending, including the contentious coverage of weight loss drugs and the broader implications of drug pricing and healthcare system reforms. Join them as they navigate through the intertwining paths of policy, healthcare costs, and the future of Medicare Advantage in an ever-changing healthcare environment.------

11 - Inflation | Jobs & the Fed | Top-heavy Nasdaq & S&P500 | Pharma solution for many chronic diseases | Rite-Aid debt concerns

Download our free app to listen on your phone